Literature DB >> 33584543

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues.

Marco Gallo1,2, Severo Campione3, Valentina Di Vito4, Nicoletta Fortunati1, Fabio Lo Calzo5, Erika Messina6, Rosaria Maddalena Ruggeri6, Antongiulio Faggiano4, Annamaria Anita Livia Colao5.   

Abstract

Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain. In the present short review of the medical literature on this topic, we have evaluated in details their epidemiology, risk factors, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. We have thus been able to identify a number of open issues regarding primary neuroendocrine neoplasms of the breast that need to be clarified. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.
Copyright © 2021 Gallo, Campione, Di Vito, Fortunati, Lo Calzo, Messina, Ruggeri, Faggiano and Colao.

Entities:  

Keywords:  breast cancer; breast carcinoma; breast neuroendocrine neoplasms; neuroendocrine; review

Mesh:

Year:  2021        PMID: 33584543      PMCID: PMC7874233          DOI: 10.3389/fendo.2020.610230

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  61 in total

1.  Is detection of endocrine cells in breast adenocarcinoma of diagnostic and clinical significance?

Authors:  A Sapino; G Bussolati
Journal:  Histopathology       Date:  2002-03       Impact factor: 5.087

2.  Primary neuroendocrine breast carcinoma.

Authors:  Pablo Menéndez; Esther García; Lorenzo Rabadán; Ricardo Pardo; David Padilla; Pedro Villarejo
Journal:  Clin Breast Cancer       Date:  2012-04-17       Impact factor: 3.225

3.  Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma.

Authors:  Bing Wei; Tian Ding; Yan Xing; Wei Wei; Zhen Tian; Feng Tang; Susan Abraham; Khazi Nayeemuddin; Kelly Hunt; Yun Wu
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

4.  Primary mammary small-cell carcinoma: a molecular analysis of 2 cases.

Authors:  M P Hoang; A Maitra; A F Gazdar; J Albores-Saavedra
Journal:  Hum Pathol       Date:  2001-07       Impact factor: 3.466

Review 5.  Primary neuroendocrine breast cancer, how much do we know so far?

Authors:  Homam Alkaied; Kassem Harris; Basem Azab; Qun Dai
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

6.  Invasive neuroendocrine carcinoma of the breast: a prognostic research of 107 Chinese patients.

Authors:  Y Zhang; Z Chen; Y Bao; Z Du; Q Li; Y Zhao; F Tang
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

7.  INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.

Authors:  Huda Razvi; Julia Y Tsang; Ivan K Poon; Siu-Ki Chan; Sai-Yin Cheung; Ka-Ho Shea; Gary M Tse
Journal:  Pathology       Date:  2020-09-17       Impact factor: 5.306

8.  Refinement of breast cancer classification by molecular characterization of histological special types.

Authors:  B Weigelt; H M Horlings; B Kreike; M M Hayes; M Hauptmann; L F A Wessels; D de Jong; M J Van de Vijver; L J Van't Veer; J L Peterse
Journal:  J Pathol       Date:  2008-10       Impact factor: 7.996

9.  Primary Neuroendocrine Carcinoma of the Breast: Histopathological Criteria, Prognostic Factors, and Review of the Literature.

Authors:  Lena Marinova; Doroteya Malinova; Snezhinka Vicheva
Journal:  Case Rep Pathol       Date:  2016-10-20

10.  Primary neuroendocrine carcinoma of the breast: report of 2 cases and literature review.

Authors:  Fernando Collado-Mesa; Jose M Net; Geetika A Klevos; Monica M Yepes
Journal:  Radiol Case Rep       Date:  2017-01-05
View more
  2 in total

Review 1.  Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.

Authors:  Yukinori Ozaki; Sakiko Miura; Ryosuke Oki; Teppei Morikawa; Keita Uchino
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

2.  NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells.

Authors:  Clotilde Raynard; Xingjie Ma; Anda Huna; Nolwenn Tessier; Amélie Massemin; Kexin Zhu; Jean-Michel Flaman; Florentin Moulin; Delphine Goehrig; Jean-Jacques Medard; David Vindrieux; Isabelle Treilleux; Hector Hernandez-Vargas; Sylvie Ducreux; Nadine Martin; David Bernard
Journal:  Aging Cell       Date:  2022-06-02       Impact factor: 11.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.